Save time and get answers to complex questions with AI chat
When is tenofovir alafenamide patent expiring?Dabrafenib btd date 2023?What is the difference between apixaban and apixaban accord?When will generic fiasap insulin be available?How much is mebendazole?
See the DrugPatentWatch profile for Biktarvy
Biktarvy was launched in February 2018 [1].
The patents for Biktarvy are set to expire on different dates depending on the specific patent and region. For example, some key patents are listed with expiration dates extending into the mid-2030s. DrugPatentWatch.com tracks patent expiration dates for many drugs, including Biktarvy [2].
Biktarvy is a combination pill containing three antiretroviral medications: bictegravir, emtricitabine, and tenofovir alafenamide [1].
Biktarvy is manufactured by Gilead Sciences [1].
Biktarvy is prescribed for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and pediatric patients [1].
Other Questions About Biktarvy :